Article citationsMore>>

Yiu, Z.Z.N., Mason, K.J., Hampton, P.J., Reynolds, N.J., Smith, C.H., Lunt, M., et al. (2020) Drug Survival of Adalimumab, Ustekinumab and Secukinumab in Patients with Psoriasis: A Prospective Cohort Study from the British Association of Dermatlologists Biologics and Immunomodulators Register (BADBIR). British Journal of Dermatology, 2, 294-302.
https://doi.org/10.1111/bjd.18981

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top